Ceftazidime-avibactam for the treatment of febrile neutropenia in HSCT recipients and acute leukemia patients post induction chemotherapy

Ceftazidime-avibactam for the treatment of febrile neutropenia in HSCT recipients and acute leukemia patients post induction chemotherapy

Abstract Febrile neutropenia is a major complication in patients with acute leukemia or those undergoing hematopoietic stem cell transplantation (HSCT). Understanding patient characteristics and susceptibility patterns in febrile neutropenia is essential for appropriate antimicrobial therapy. First-...

Full description

Saved in:
Bibliographic Details
Main Authors: Jim Abi Frem, Alicia Khazzeka, Fatima Allaw, Caren Doueiry, Racha Ghoussaini, Rayan Mohamad, Zeina A. Kanafani
Format: Article
Language:English
Published: Nature Portfolio 2024-12-01
Series:Scientific Reports
Subjects:
Febrile neutropenia
Acute leukemia
Hematopoietic stem cell transplant
Ceftazidime-avibactam
Mortality
Morbidity
Online Access:https://doi.org/10.1038/s41598-024-82795-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-024-82795-9

Similar Items